Search Clinical Trials
597,593 trials
ID
Status
Phase
Title
Sponsor
NCT07755176
Patient-reported Outcomes Following Percutaneous Ablation of Desmoid TumorsMayo ClinicEnrolling By Invitation
NCT07755176Enrolling By Invitation
—
Patient-reported Outcomes Following Percutaneous Ablation of Desmoid TumorsMayo Clinic
NCT07755449
CLEAR (Cervical Lymphatic Exclusion in Adjuvant Radiation)Institut Català d'OncologiaRecruitingPhase 2
NCT07755449Recruiting
Phase 2
CLEAR (Cervical Lymphatic Exclusion in Adjuvant Radiation)Institut Català d'Oncolog...
NCT07754474
A Study to Test How Well Different and Multiple Doses of BI 3034701 Are Tolerated in People Living With Overweight or ObesityBoehringer IngelheimNot Yet RecruitingPhase 1
NCT07754474Not Yet Recruiting
Phase 1
A Study to Test How Well Different and Multiple Doses of BI 3034701 Are Tolerate...Boehringer Ingelheim
NCT07755098
Integration of New Generation Multi-omics Analyses for the Diagnosis of Genetic Neurodevelomental DisordersCentre Hospitalier Universitaire DijonNot Yet RecruitingNot Applicable
NCT07755098Not Yet Recruiting
Not Applicable
Integration of New Generation Multi-omics Analyses for the Diagnosis of Genetic...Centre Hospitalier Univer...
NCT07754253
Effectiveness of Epigallocatechin-3-Gallate (Green Tea Extract) as Adjunctive Locally Delivered Nanotherapeutic in the Treatment of Stage II PeriodontitisMansoura UniversityRecruitingPhase 1
NCT07754253Recruiting
Phase 1
Effectiveness of Epigallocatechin-3-Gallate (Green Tea Extract) as Adjunctive Lo...Mansoura University
NCT07754409
Aspects of Quality of Life During Adjuvant Oncological Treatment for Locally Advanced Lung Cancer Which Include Immune Checkpoint Inhibitor.Göteborg UniversityNot Yet Recruiting
NCT07754409Not Yet Recruiting
—
Aspects of Quality of Life During Adjuvant Oncological Treatment for Locally Adv...Göteborg University
NCT07754240
A Clinical Investigational Study of AnkuraTM II AAA, IE and AE Stent Graft System for Endovascular Treatment of Abdominal Aortic AneurysmLifetech Scientific (Shenzhen) Co., Ltd.Not Yet RecruitingNot Applicable
NCT07754240Not Yet Recruiting
Not Applicable
A Clinical Investigational Study of AnkuraTM II AAA, IE and AE Stent Graft Syste...Lifetech Scientific (Shen...
NCT07754318
Aneurysm Treatment Using the Heli-FX™ EndoAnchor™ System China Study(ATHENA)Medtronic CardiovascularNot Yet RecruitingNot Applicable
NCT07754318Not Yet Recruiting
Not Applicable
Aneurysm Treatment Using the Heli-FX™ EndoAnchor™ System China Study(ATHENA)Medtronic Cardiovascular
NCT07753967
Efficacy of Chloroquine-Primaquine Treatment for Uncomplicated Plasmodium Vivax MalariaJimma UniversityCompletedNot Applicable
NCT07753967Completed
Not Applicable
Efficacy of Chloroquine-Primaquine Treatment for Uncomplicated Plasmodium Vivax...Jimma University
NCT07756138
Filsuvez in Moderate-to-Severe Epidermolysis Bullosa SimplexStanford UniversityNot Yet RecruitingPhase 2
NCT07756138Not Yet Recruiting
Phase 2
Filsuvez in Moderate-to-Severe Epidermolysis Bullosa SimplexStanford University
NCT07755670
Exploration of Brain Functional Networks in Patients With Hidradenitis Suppurativa Using fMRISecond Xiangya Hospital of Central South UniversityRecruiting
NCT07755670Recruiting
—
Exploration of Brain Functional Networks in Patients With Hidradenitis Suppurati...Second Xiangya Hospital o...
NCT07755930
Marsili Syndrome as a Gateway to Novel Analgesic TargetsAalborg UniversityNot Yet RecruitingNot Applicable
NCT07755930Not Yet Recruiting
Not Applicable
Marsili Syndrome as a Gateway to Novel Analgesic TargetsAalborg University
NCT07754071
Clinical Validation of an Artificial Intelligence System for De-termining Fetal Lie and Position in 3rd TrimesterCopenhagen Academy for Medical Education and SimulationRecruiting
NCT07754071Recruiting
—
Clinical Validation of an Artificial Intelligence System for De-termining Fetal...Copenhagen Academy for Me...
NCT07755917
Preoperative Home-based Multimodal Prehabilitation Based on 5G + Artificial Intelligence Mobile HealthDongying People's HospitalNot Yet RecruitingNot Applicable
NCT07755917Not Yet Recruiting
Not Applicable
Preoperative Home-based Multimodal Prehabilitation Based on 5G + Artificial Inte...Dongying People's Hospita...
NCT07754513
Circulating Tumor Extracellular Vesicles for Non-Invasive Monitoring of Metastatic Colorectal CancerFondazione Policlinico Universitario Agostino Gemelli IRCCSNot Yet Recruiting
NCT07754513Not Yet Recruiting
—
Circulating Tumor Extracellular Vesicles for Non-Invasive Monitoring of Metastat...Fondazione Policlinico Un...
NCT07756008
Bladder-Sparing Treatment With Disitamab Vedotin and Toripalimab With or Without Pelvic Lymph Node Dissection in Bladder CancerSun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot Yet RecruitingPhase 2
NCT07756008Not Yet Recruiting
Phase 2
Bladder-Sparing Treatment With Disitamab Vedotin and Toripalimab With or Without...Sun Yat-Sen Memorial Hosp...
NCT07755410
A Study to Evaluate Safety and Efficacy of ALKS 7290 Compared With Placebo in Adult Participants With Attention Deficit Hyperactivity Disorder (ALKS 7290-201)Alkermes, Inc.RecruitingPhase 2
NCT07755410Recruiting
Phase 2
A Study to Evaluate Safety and Efficacy of ALKS 7290 Compared With Placebo in Ad...Alkermes, Inc.
NCT07754058
External Versus Powered Endoscopic Dacryocystorhinostomy With Mitomycin C for Primary Acquired Nasolacrimal Duct ObstructionMilitary Institute od Medicine National Research InstituteCompletedNot Applicable
NCT07754058Completed
Not Applicable
External Versus Powered Endoscopic Dacryocystorhinostomy With Mitomycin C for Pr...Military Institute od Med...
NCT07755267
Cutoff Assessment for Codeine in Fingerprint Sweat Relative to Oral Fluid, Following Controlled, Oral Administration of Codeine Phosphate Tablets to 40 Healthy AdultsCliantha ResearchCompleted
NCT07755267Completed
—
Cutoff Assessment for Codeine in Fingerprint Sweat Relative to Oral Fluid, Follo...Cliantha Research
Result Breakdown
Not yet recruiting11 (55%)
Recruiting5 (25%)
Completed3 (15%)
Enrolling by invitation1 (5%)
not_applicable8 (40%)
Not Specified6 (30%)
Phase 24 (20%)
Phase 12 (10%)